Websites within the Pittsburgh space that use monoclonal antibodies to deal with and stop COVID-19

When Chris Johnson was treated with monoclonal antibodies at UPMC in July, he became the first in the country to receive the infusion under the recently issued emergency clearance from the Food and Drug Administration. Johnson contracted COVID-19 months after being fully vaccinated, but said he was lucky enough to know what to ask about. “I was very aware of the monoclonal antibodies while working on tele-tracking because we are tracking the distribution and use of these across the country,” said Johnson. Treatment consists of a one hour infusion followed by another hour of observation. Dr. Graham Snyder said UPMC now has infusion sites throughout the Pittsburgh area and hospital system. “The advantage of monoclonal antibodies as a treatment is that they can be adapted to the virus that is changing, and we had that, we had a few monoclonal antibodies that were effective against the early variants but not the ones now Snyder said the antibodies are now also available to prevent the virus. “We can make the monoclonal antibodies available to someone who has been exposed to the virus and is not yet infected,” said Snyder. “It’s limited It’s not available to everyone, there are some criteria for who can get it, but a large part of the community would be candidates for it or you’ve been told by health officials that you’ve been exposed, that’s another reason to get in touch. ” Johnson said he believed the treatment had speeded up his recovery. He said he felt the effects within 24 hours. “I almost felt like the disease was going back a little,” said Johnson. Details on treatment with monoclonal antibodies: www.upmc.com/antibodytreatment For more information: 866-804-5251

PITTSBURGH –

When Chris Johnson was treated with monoclonal antibodies at UPMC in July, he became the first in the country to receive the infusion under the recently issued emergency clearance from the Food and Drug Administration.

Johnson contracted COVID-19 months after being fully vaccinated, but said he was lucky enough to know what to ask about.

“I was very aware of my work in tele-tracking the monoclonal antibodies because we are tracking the distribution and use of these across the country,” said Johnson.

Treatment is a one hour infusion followed by another hour of observation.

Dr. Graham Snyder said UPMC now has infusion sites throughout the Pittsburgh area and throughout its hospital system.

“The advantage of monoclonal antibodies as a treatment is that they can be adapted to the changing virus and we had that, we had a couple of monoclonal antibodies that were effective against the early variants but not the ones that are now circulating, though They have been updated and replaced with monoclonal antibodies like the one we have just started giving, which is effective against the Delta variant, “said Snyder.

Snyder said the antibodies are now also available to help prevent the virus.

“We can make the monoclonal antibodies available to someone who has been exposed to the virus and has not yet been infected,” said Snyder. “It’s limited. It’s not available to everyone, there are some criteria for who can get it, but a large part of the community would be candidates for it or if you’ve been told by health officials that you’ve been exposed, that’s another reason to get in touch. “

Johnson said he believed the treatment had speeded up his recovery. He said he felt the effects within 24 hours.

“I felt like it was almost like the disease was receding a bit,” said Johnson.

Details on treatment with monoclonal antibodies: www.upmc.com/antibodytreatment

More details: 866-804-5251